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Abstract 
We have introduced the first 3 cases of inflammatory myopathy with abundant 
macrophages (IMAM) from Asian countries. IMAM was diagnosed based upon the 
infiltration of CD68+ macrophages into the biopsied specimens, especially the fascia. 
Proximal skeletal muscle symptoms and signs, elevation of creatin kinase (CK) and 
myogenic change in electromyography (EMG) were found in all the cases and magnetic 
resonance imaging (MRI) clearly revealed the thickening of fascia. Since 
dermatomyositis (DM)-specific skin alterations were not found in the present cases, 
none of the patients fulfilled the Bohan and Peter’s criteria for DM whereas anti-PL-7 
antibody was detected in case 1. In addition, CD20+ B-cell infiltration into the fascia 
was also demonstrated in all the cases, indicating that further transition to DM could be 
indicated. Severe illness of macrophage activation syndrome (MAS) and acute 
respiratory distress syndrome (ARDS) complicated in case 1 which resolved by 




anti-ARS Abs: anti-aminoacyl tRNA synthetase antibodies 
anti-CADM-140kD Abs: anti-clinically amyopathic dermatomyositis-140kD   
polypeptide antibodies   
anti-155kD/140kD Abs: anti-155kD/140kD polypeptide antibodies  
ARDS: acute respiratory distress syndrome 
CHP: cytophagic histiocytic panniculitis 
CK: cretin kinase 
CT: computed tomography 
DM: dermatomyositis 
EMG: electromyography 
IMAM: inflammatory myopathy with abundant macrophages 
MAS: macrophage activation syndrome 
MRI: magnetic resonance imaging 
STIR: short-time inversion recovery 
TNF : tumour necrosis factor  
soluble TNR receptor: sTNFR 
 
Introduction 
In addition to the classical inflammatory myopathies, i.e. polymyositis, dermatomysitis 
(DM) and inclusion body myositis, the spectrum of inflammatory myopathies has 
recently expanded, especially concerning inflammatory myopathy with predominance 
of macrophages into the tissues, i.e. macrophagic myofasciitis and inflammatory 
myopathy with abundant macrophages (IMAM) (1-3). Clinically, IMAM is unrelated to 
aluminium hydroxide-adjuvanted vaccines and characterized by scaly DM-like or 
atypical non-DM-like skin alterations and proximal muscle weakness, thus, leading to 
the clinical diagnosis of DM, atypical systemic lupus erythematosus or overlap 
syndrome (1-3). Histologically, infiltration of macrophages into the fascia, rather than 
muscle, is characteristic for IMAM (1-3). A relationship and even a continuum between 
DM and IMAM is suggested in a case report (2), however, it remains unclear whether 
IMAM is distinct or not from DM (1-3). This is a first report of IMAM from Asian 
countries. Furthermore, our report contains new informations regarding to 
myositis-specific autoantibodies and magnetic resonance imaging (MRI) of the affected 
tissues in patients with IMAM. 
 
Case report 
Table 1 summarized demography of the present 3 cases. Diagnosis of IMAM was based 
upon the infiltration of CD68+ macrophages into the biopsied specimens (Fig. 1).  
They had not been received vaccines containing aluminum hydroxide. Since DM 
specific skin alternations, including heliotrope erythema, Gotron’s papuls and Gotron’s 
signs, were not found in all of 3 cases, our present cases did not fulfill Bohan and 
Peter’s criteria for DM (4, 5). Figure 1 shows muscle biopsy specimens of 3 cases. 
Thickening of fascia was determined in all of biopsied specimens (Fig. 1). A number of 
CD68+ macrophages associated with CD4+ T-lymphocytes (Fig.1), CD8+ 
T-lymphocytes (Fig. 1) and CD20+ B-cells (Fig. 1), but few inflammatory cells in the 
muscle tissue. 
  Figure 2 A-C show short-time inversion recovery (STIR; TR 3000, TE 12, T1 160) 
images in plain MRI of the affected muscles. The thickening of fascia was clearly 
demonstrated by MRI whereas STIR high legions were not so obvious in the muscle 
tissue. These alternations in MRI reflect similarly the changes found by the histological 
study. Myogenic change of the affected muscles was determined in all the 3 cases (data 
not shown).  
  Analysis of myositis-specific autoantibodies of anti-aminoacyl tRNA synthetase 
(ARS) antibodies, anti-clinically amyopathic dermatomyositis -140kD polypeptide 
antibodies (anti-CADM-140 Abs) and anti-155kD/140kD polypeptide antibodies 
(anti-155/140kD Abs) was performed in the present cases as we recently reported (6, 7). 
As shown in Fig. 2D, anti-PL-7 antibody (Ab) was detected in sera from case 1 whereas 
none of other myositis-specific autoantibodies was found in all of 3 cases. Anti-U1 RNP 
Ab was detected in case 3 (Fig. 2D).  
  We briefly described a clinical course of case 1 who complicated with cytophagic 
histiocytic panniculitis (CHP) of both upper and lower extremities at clinical 
examination. High serum fibrin degradation products (171 µg/ml), D-dimer (131.4 
µg/ml) and ferritin (12,786 ng/ml; normal range, 4.0-87.0 ng/ml) were demonstrated at 
admission. A computed tomography (CT) scan of the chest showed diffuse 
consolidation and ground glass opacities throughout both lungs (Fig. 2E). Cell findings 
of bronchoalveolar lavage fluid revealed a normal appearance, but increased neutrophils 
(30%) and lymphocytes (25%), which were suggestive as a pattern of diffuse alveolar 
damage. The bone marrow smear showed normal cellularity with several 
hemophagocytic macrophages. Thus, in addition to CHP, this patient was considered to 
suffer from macrophage activation syndrome (MAS) and acute respiratory distress 
syndrome (ARDS). MAS [This case met the diagnostic criteria for MAS (8) as well as 
ARDS (9) ]. Intensive combination therapy, including plasmapheresis (four times), 
leukocytapheresis (two times), polymyxin B immobilized fiber direct hemoperfusion 
(once), pulse methylprednisolone (four times after referral, a total of six times), 
sivelestat sodium (250 mg/day for 14 days), and oral administration of 
immunosuppressants (tacrolimus at first, changed to cyclosporine A), was initiated. 
These therapies were highly effective and most of the above abnormalities recovered 
within 2 weeks. High serum tumour necrosis factor  (TNF-, soluble TNR receptor 1 
(sTNFR1), and sTNFR2 levels were determined before the treatment [TNF- = 131.8 
pg/ml (11.9 ± 6.4 pg/ml from 16 healthy controls), sTNFR1 = 7.0 ng/ml (1.2 ± 1.1 
ng/ml from 13 healthy controls), sTNFR2 = 30.9 ng/ml (3.0 ± 1.3 ng/ml from 13 
healthy controls)] which rapidly reduced at 2 weeks later (TNF- reduced to 20.7 
pg/ml, sTNFR1 reduced to 4.2 ng/ml, and sTNFR2 reduced to 14.8 ng/ml). Spontaneous 
remission was not also demonstareted in case 2 and case 3, and glucocorticoid required 
for the remission (Table 1). 
 
Discussion 
IMAM is recently described from European countries that have reported to resemble 
with DM (1-3). Our present 3 cases are first report of IMAM from Asian countries. All 
of our cases represented proximal skeletal muscle symptoms and signs as well as 
elevation of CK, however, are not fulfilled with Bohan and Peter’s criteria for DM. That 
may follow the previous reports that IMAM is sometimes defined as atypical DM 
clinically (1-3). It is interesting to note that our present 3 cases show the efficacy of 
plain MRI to identify thickening of fascia which almost reflects upon the histological 
finding. Predominant inflammation in the fascia rather than muscle is a characteristic of 
IMAM (1-3). Plain MRI is a non-invasive method, thus, we recommend plain MRI for 
early recognition of IMAM.  
  Severe illness was induced in case 1 due to MAS which is consistent with previous 
report that IMAM patient was dead from hemophagocytic syndrome and disseminated 
intravascular coagulopathy (1). High TNF-related cytokines are believed to reflect the 
activation status of macrophage-lineage cells (10). High serum concentrations of 
TNF- sTNFR1 and sTNFR2 was demonstrated in case 1 before treatment that was 
rapidly decreased by intensive combination therapy. These data really indicate that 
macrophages critically involve in the pathologic process of IMAM. 
  Brunn et al. have compared the cellular subset in affected tissues of IMAM with DM 
(3). They have found that the difference, i.e., few infiltration of B-cells and plasmatoid 
dendritic cells whereas more TNF- producing cells in IMAM as compared with DM 
(3). Brunn et al. have explained that the difference may reflect the two stages of one 
disorder or two distinct disease entities. From this point of view, we have evaluated the 
present 3 cases. All 3 cases have been screened by myositis-specific autoantibodies of 
anti-ARS antibodies, anti-CADM-140 Abs and anti-155/140kD Abs, respectively which 
is the first time study for IMAM. Similarity of IMAM of the present cases with DM 
could be suspected since case 1 expresses anti-PL-7 Ab and infiltration of B-cells into 
the fascia is found in all of 3 cases. Difference of B-cell infiltration into the fascia in 
patients with IMAM could be derived from the racial difference. Yamasaki et al. have 
examined the characteristic of anti-PL-7 Ab-positive DM patients from Japanese 
population and reported that these patients are milder in skeletal muscle involvement as 
compared with anti-Jo-1 Ab-positive patients (11), again indicating the development of 
atypical DM further in case 1. Further clinical evaluation, in either case, are necessary 
to answer the questions. 
 
Figure Legends 
Figure 1. Histologic examination of the present study. A-F; Case 1, a prominent cellular 
inflammation was found in the fascia. A; control staining by IgG (original magnification, 
100 x) B; anti-CD68 monoclonal antibody (mAb) (original magnification, 100 x) C; 
anti-CD68 mAb (original magnification, 400 x) D; anti-CD4 mAb (original 
magnification, 100 x) E; anti-CD8 mAb (original magnification, 100 x) F; anti-CD20 
mAb (original magnification, 100 x). Remarkable infiltration of CD68+ macrophages, 
along with CD4+ T-lymphocytes, CD8+ T-lymphocytes and CD20+ B-cells were found.  
G and H; Case 2, a prominent cellular inflammation was found in the fascia. G; 
Hematoxylin and eosin staining (original magnification, 100 x) H; anti-CD68 mAb 
(original magnification, 100 x).  I; Case 3, a prominent cellular inflammation of 
macrophages was found in the fascia. I; anti-CD68 mAb (original magnification, 200 x).  
 
Figure 2. MRI of muscle, chest CT and silver staining of tRNA immunoprecipitated 
with sera of the present study. Plain STIR MRI of case 1 (A; right brachial muscle), 
case 2 (B; right quadriceps muscle) and case 3 (C; right quadriceps muscle) before 
therapy. Arrows indicate the sites of thickening of fascia.  D; Plain chest CT of case 1 
before therapy shows diffuse consolidation and ground glass opacities throughout both 
lungs.  E;. Silver staining of tRNA immunoprecipitated with sera as described in the 
text ( ). Lane 1 and 7; total RNA, Lane 2; anti-U1 RNP Ab-positive control serum, Lane 
3; Serum of case 3, anti-U1 RNP Ab positive. Lane 4; Serum of case 2, negative. Lane 
5; anti-PL-7 Ab-positive control serum, Lane 6; Serum of case 1, anti-PL-7 Ab positive.  
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Table 1. Demographic feature of 3 patients with IMAM 
Items Case 1 Case 2 Case 3 
Age / Gender 45 y.o. / Female 55 y.o. / Female 58 y.o. / Male 
Muscle symptoms    
  Myalgia + + + 
  Weakness + + + 
Skin lesions    
  Heliotrope erythema - - - 
  Gotron’s papuls - - - 
  Gotron’s signs - - - 






Myositis-specific Abs anti-PL-7 Ab - - 
Myogenic change in 
electromyography 
+ + + 




        
